Excessive Platelet Sterilization Potentially Dangerous
|
By LabMedica International staff writers Posted on 22 Jun 2014 |
Chemical processes used to sterilize blood products could lead to serious health issues in transfusion recipients, according to a new study.
Researchers at Linköping University (Sweden), Université Laval (Québec, Canada), and other institutions documented the effects of pathogen reduction (PR) systems on microRNA and mRNA levels in platelets stored in the blood bank, and assessed their impact on platelet activation and function. The researchers compared the two standard PR methods, gamma irradiation alone or irradiation in combination with chemical substances that inactivate pathogenic agents by cross-linking to their nucleic acids (DNA and RNA).
The researchers found that unlike platelets subjected to gamma irradiation or stored in additive solution, the ones that were treated by the two PR systems available on the market, Intercept and Mirasol, aggregated badly, which worsened wound healing. Intercept also eradicated the nucleic acids of the platelets, causing them to become overactive and reduced in volume. Gamma radiation, on the other hand, had no damaging effects on the blood platelets. PR neither affected platelet microRNA synthesis or function, nor induced cross-linking of microRNA-sized endogenous platelet RNA species. The study was published early online on April 21, 2014, in Platelets.
“The processes that are used target the genetic material of pathogenic organisms; they were developed more than 20 years ago, before we understood the importance of the genetic material contained in platelets,” said corresponding author Patrick Provost, MD, of Université Laval. “These treatments activate blood platelets, triggering the release of RNA. The platelets end up depleted of RNA, so once transfused, they're unable to do what they normally would.”
“The problem is also that the blood platelets have nucleic acids that are very important for their wound healing abilities and communication with other cells,” added lead author clinical biochemist Abdimajid Osman, PhD, a researcher in Linköping University. “If they are eradicated it can damage the blood cells and lead to more severe bleeding for the patient. Our recommendation to blood centers is not to use any of the substances, only irradiation treatment.”
The function of platelets goes far beyond their role in blood coagulation and wound healing. They contain up to a third of the human genome in the form of ribonucleic acid (RNA), allowing them to synthesize over 1,000 proteins essential to the normal functioning of the human body. In contrast to other donated blood products, blood platelets must be stored at room temperature as they do not tolerate the cold. This entails a risk that pathogens such as bacteria and viruses develop and follow the platelets into the patient’s blood system. The consequence can be blood poisoning, in the worst case leading to death.
Related Links:
Linköping University
Université Laval
Researchers at Linköping University (Sweden), Université Laval (Québec, Canada), and other institutions documented the effects of pathogen reduction (PR) systems on microRNA and mRNA levels in platelets stored in the blood bank, and assessed their impact on platelet activation and function. The researchers compared the two standard PR methods, gamma irradiation alone or irradiation in combination with chemical substances that inactivate pathogenic agents by cross-linking to their nucleic acids (DNA and RNA).
The researchers found that unlike platelets subjected to gamma irradiation or stored in additive solution, the ones that were treated by the two PR systems available on the market, Intercept and Mirasol, aggregated badly, which worsened wound healing. Intercept also eradicated the nucleic acids of the platelets, causing them to become overactive and reduced in volume. Gamma radiation, on the other hand, had no damaging effects on the blood platelets. PR neither affected platelet microRNA synthesis or function, nor induced cross-linking of microRNA-sized endogenous platelet RNA species. The study was published early online on April 21, 2014, in Platelets.
“The processes that are used target the genetic material of pathogenic organisms; they were developed more than 20 years ago, before we understood the importance of the genetic material contained in platelets,” said corresponding author Patrick Provost, MD, of Université Laval. “These treatments activate blood platelets, triggering the release of RNA. The platelets end up depleted of RNA, so once transfused, they're unable to do what they normally would.”
“The problem is also that the blood platelets have nucleic acids that are very important for their wound healing abilities and communication with other cells,” added lead author clinical biochemist Abdimajid Osman, PhD, a researcher in Linköping University. “If they are eradicated it can damage the blood cells and lead to more severe bleeding for the patient. Our recommendation to blood centers is not to use any of the substances, only irradiation treatment.”
The function of platelets goes far beyond their role in blood coagulation and wound healing. They contain up to a third of the human genome in the form of ribonucleic acid (RNA), allowing them to synthesize over 1,000 proteins essential to the normal functioning of the human body. In contrast to other donated blood products, blood platelets must be stored at room temperature as they do not tolerate the cold. This entails a risk that pathogens such as bacteria and viruses develop and follow the platelets into the patient’s blood system. The consequence can be blood poisoning, in the worst case leading to death.
Related Links:
Linköping University
Université Laval
Latest Hematology News
- Serial Blood Samples Reveal Leukemia’s Evolution Decades Before Diagnosis
- Study Confirms Blood Products Remain Viable After Three Weeks in the Arctic
- New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients
- Newly Certified FISH Probes Support Cytogenetic Testing in Blood Cancers
- Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification
- New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL
- Handheld Point-of-Care Test Aims to Enable Rapid Coagulation Assessment in Trauma
- New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis
- New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
- New Automated Hemostasis Systems Become Available Across US Laboratories
- Updated Ferritin Thresholds Improve Detection of Iron Deficiency
- Variation in AML Residual Disease Testing Prompts Push for Standardization
- Hidden Molecular Mechanism Behind HIT Blood-Clotting Disorder Revealed
- Borderline Anemia May Carry Higher Risk Than Current Thresholds Suggest
- Biomarker-Guided Framework Aims to Guide Mantle Cell Lymphoma Therapy
- New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome
Channels
Clinical Chemistry
view channel
Updated PSA Testing Guidelines Support Early Prostate Cancer Detection
Prostate cancer is the second leading cause of cancer-related death among men in the United States, with an estimated 333,830 new cases and 36,320 deaths this year, according to the American Cancer Society.... Read more
Antibody-Free Blood Test Detects Rheumatic Heart Disease Biomarker
Rheumatic heart disease (RHD) causes hundreds of thousands of deaths annually, disproportionately affecting children and young adults in low- and middle-income countries. Early detection remains challenging... Read moreMolecular Diagnostics
view channel
AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026
Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more
AMP 2026 Highlights Advances in Molecular Testing for Pediatric Diseases
Advances in molecular diagnostics are creating new opportunities to identify inherited diseases earlier, improve the classification of childhood cancers, and track infectious disease outbreaks affecting children.... Read more
Genomic Studies Investigate Treatment Response and Inherited Risk in Sarcoma
Tempus AI (Chicago, IL, USA) will present six abstracts, including three oral presentations, at the Connective Tissue Oncology Society (CTOS) 2026 Annual Meeting, taking place November 18–21 in Seoul, South Korea.... Read moreHematology
view channel
Serial Blood Samples Reveal Leukemia’s Evolution Decades Before Diagnosis
Acute myeloid leukemia (AML) is an aggressive blood cancer affecting approximately 2,700 people in the U.K. annually, with only about one in six patients surviving five years after diagnosis.... Read more
Study Confirms Blood Products Remain Viable After Three Weeks in the Arctic
Trauma and hemorrhage care in Canada’s High Arctic is complicated by long evacuation times, extreme temperatures, and limited access to blood products. In remote military and northern communities, reaching... Read moreImmunology
view channel
Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis
Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more
Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions
Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read moreMicrobiology
view channel
Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum
Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more
Automated Microbial Identification and Susceptibility System Gains FDA Clearance
Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more
Gastrointestinal Flex Assay Gains EU Certification for Tailored Pathogen Testing
Gastrointestinal infections can be caused by bacterial, viral, or parasitic pathogens, making targeted test selection important for clinical laboratories. Fixed syndromic panels may be broader than necessary... Read more
Molecular Panels Gain FDA Clearance for One-Hour Gastrointestinal Pathogen Testing
Acute infectious gastroenteritis, caused by viral, bacterial, and parasitic pathogens, remains a significant global health concern that inflames the gastrointestinal tract. Symptoms such as diarrhea, vomiting,... Read morePathology
view channel
New Training Approach Helps AI Distinguish Neighboring Cells in Tissue
Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more
Review Highlights Progress and Validation Needs for AI in Digital Pathology
Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more
Breakthrough-Designated Cytology Test Supports Oral Cancer Risk Assessment
Oral cavity and oropharyngeal cancers remain a significant diagnostic challenge, with more than 60,000 Americans expected to be diagnosed in 2026 and more than 13,000 expected to die from these cancers.... Read more
AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification
In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read moreTechnology
view channel
New qPCR Master Mixes Offer Broad Compatibility for Routine Research
Quantitative PCR (qPCR) workflows require consistent reagent performance across instruments and assay formats. Laboratories must also manage costs without changing established protocols.... Read more
Multi-Agent AI Framework Supports Laboratory Quality and Workflow Monitoring
Clinical laboratories analyze blood, urine, tissue, and other bodily fluids to support disease diagnosis and treatment. Rising test volumes, workforce shortages, and increasingly complex diagnostics are... Read moreIndustry
view channel
Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study
Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan
Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more







